Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.
Ther Adv Musculoskelet Dis. 2021 Jun 11;13:1759720X211014020. doi: 10.1177/1759720X211014020. eCollection 2021.
Ther Adv Musculoskelet Dis. 2021.
PMID: 34178124
Free PMC article.
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.
Varenna M, Gatti D, Zucchi F, Crotti C, Braga V, Iolascon G, Frediani B, Nannipieri F, Rossini M.
Varenna M, et al.
Ther Adv Musculoskelet Dis. 2022 Dec 19;14:1759720X221142274. doi: 10.1177/1759720X221142274. eCollection 2022.
Ther Adv Musculoskelet Dis. 2022.
PMID: 36569491
Free PMC article.
Item in Clipboard
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.
De Biasi S, Cerri S, Bianchini E, Gibellini L, Persiani E, Montanari G, Luppi F, Carbonelli CM, Zucchi L, Bocchino M, Zamparelli AS, Vancheri C, Sgalla G, Richeldi L, Cossarizza A.
De Biasi S, et al.
BMC Med. 2015 Nov 9;13:277. doi: 10.1186/s12916-015-0515-0.
BMC Med. 2015.
PMID: 26552487
Free PMC article.
Item in Clipboard
Cite
Cite